The QualityStocks Daily Thursday, March 7th, 2019

Today's Top 3 StockMarketWatch

Schaeffer's (BPTH) +223.29%

NetworkNewsWire (SGSI) +107.62%

StockMarketWatch (NMEX) +73.08%

The QualityStocks Daily Stock List

Golden Arrow Resources Corp. (GARWF)

MarketWatch, GuruFocus, Junior Mining Network, Proactive Investors, Wallet Investor, Stockhouse, Streetwise Reports, Money and Markets, Equity Clock, InvestorsHub, FutureMoneyTrends, YCharts, Investor Intel and 24hgold reported earlier on Golden Arrow Resources Corp. (GARWF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Golden Arrow Resources Corp. is an explorer and prospect generator. The Company’s focus is identifying, acquiring, and advancing precious and base metal discoveries with the aim of defining first-class deposits. Its chief emphasis is on advancing its flagship Chinchillas Silver Project in Jujuy Province, Argentina. Golden Arrow Resources is headquartered in Vancouver, British Columbia and has exploration offices in Ciudad de Mendoza, Argentina.

The Company is exploring a new portfolio of advanced projects in Chile, as well as other targets within its portfolio of over 200,000 hectares of properties in Argentina. Golden Arrow Resources is a member of the Grosso Group; a management company specializing in resource exploration.

Golden Arrow’s other Argentina projects include the Antofalla Silver-Gold-Base Metal Project in Catamarca Province; and the Don Bosco Copper-Gold Project and the Caballos Copper-Gold Project, both in La Rioja Province. Projects additionally include the Mogote Copper-Gold Project; the Pescado Gold Project; and the Frontera District - Potrerillos Gold-Silver Project. All of these projects are in San Juan Province.

Golden Arrow Resources has established a 100 percent owned subsidiary named “New Golden Explorations, Inc.” New Golden Explorations has been focused on acquiring advanced stage exploration projects with the potential to deliver sizable added share value. New Golden Explorations previously announced the acquisition of the Indiana Gold-Copper and the Atlantida Copper-Gold projects.

The Chinchillas Silver deposit will be developed into a satellite open-pit mine. The Chinchillas Silver Project features low capital expenditure and fast-tracked development utilizing infrastructure from the Pirquitas mine. It has a positive pre-feasibility study with strong economics and immediate production income from the Pirquitas mine operation.

Golden Arrow Resources established a Joint Venture (JV) with Silver Standard Resources, Inc. The JV is called Puna Operations, Inc. (POI). POI is 75 percent owned and operated by Silver Standard and owned 25 percent by Golden Arrow Resources. It was created to hold the Chinchillas project and the Pirquitas project that consist of the San Miguel open pit mine, which ended mining operations in January 2017 (the Pirquitas Pit), and the associated mineral processing facilities and tailings facility (the Pirquitas Operation) in Argentina.

Golden Arrow Resources announced this past December that its JV partner in Puna Operations declared commercial production at the Chinchillas silver-zinc-lead mine as of December 1, 2018.

This week, Golden Arrow Resources announced that it closed the second tranche of a non-brokered private placement via the issuance of 1,290,367 units at a subscription price of $0.30 per Unit for total gross proceeds to Golden Arrow of $387,110. Furthermore, because of continued robust demand, it increased the Unit offering to up to C$4.1 million in aggregate gross proceeds. All other terms of the financing will remain the same.

Golden Arrow Resources Corp. (GARWF), closed Thursday's trading session at $0.2268, down 2.54%, on 20,120 volume with 14 trades. The average volume for the last 3 months is 92,083 and the stock's 52-week low/high is $0.169/$0.49.

chart

Pura Naturals, Inc. (PNAT)

OTC Markets, Whale Wisdom, YCharts, Spotlight Growth, Stockwatch, Clay Trader, Insider Financial, Marketwired, Tip Ranks, Dividend Investor, and MarketWatch reported previously on Pura Naturals, Inc. (PNAT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean via its unique BeBetter Foam®. The Company is the manufacturer of innovative foam cleaning products for the home. It has its proprietary foam technology that absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is headquartered in Lake Forest, California.

Pura Naturals centers on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The pioneering foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

In addition, the Company has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Pura Marine division concentrates on developing solutions utilizing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Pura Naturals also has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner. In addition, the Company has its line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.

Pura Naturals has its Grease Beast products and this week the Company announced the increased synergy the Grease Beast products are experiencing. Recently, Pura Naturals attended the Orgill Dealer Market Show in Orlando, Florida, February 21 to the 23, with further very encouraging results.

Mr. Robert Doherty, Chief Executive Officer of Pura Naturals, stated, "It was a great show for the Company. There continues to be tremendous reception for the Grease Beast product line. It was our best show ever for the brand. We received the most orders during a show to date.  We are now working directly with top Orgill representatives."

Pura Naturals, Inc. (PNAT), closed Thursday's trading session at $0.0038, up 8.57%, on 1,680,759 volume with 24 trades. The average volume for the last 3 months is 5,399,376 and the stock's 52-week low/high is $0.0015/$0.079.

chart

United Cannabis Corp. (CNAB)

Stockgoodies, Cannabis Financial Network News, Stocks Impossible, Priceless Penny Stocks, Market Intelligence, Wall Street Wolves, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Marketbeat, StreetAuthority Daily, Actual Gains, Broad Street, TopPennyStockMovers, PennyStockRumors, Money Map Press, and MyBestStockAlerts reported previously on United Cannabis Corp. (CNAB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s dedication is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company formed to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, as week as services.

A biotechnology company, United Cannabis is headquartered in Denver, Colorado. United Cannabis has a majority share of Prana Therapeutics, Inc. (PTI). PTI is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopaedic markets.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. United Cannabis owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products. It is the creator of Prana Bio Nutrient Medicinals. Its A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a total solution designed to enable physicians and patients to implement and monitor effective therapy protocols.

Prana Bio Nutrient Medicinals is a complete, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and numerous non-abrasive delivery methods.

The A.C.T. Now program provides nutritional recommendations These recommendations are to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis (MS), fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many kinds of cancer.

Last month, United Cannabis announced that it entered into a Joint Venture (JV) with Blue Water Green Bridge, LLC a South Carolina company, to create an industrial hemp processing plant. The new venture is called Magnolia Botanicals LLC.

Mr. Earnest Blackmon, United Cannabis’ Chief Executive Officer, said, ''The Company's successful expansion into Colorado's industrial hemp sector was the impetus for us to seek other regions where market demand was not being met and our expertise could provide value. Working in conjunction with Blue Water not only gives us a foothold in the South East's burgeoning industrial hemp market, it also provides us with a strong financial partner.''

United Cannabis Corp. (CNAB), closed Thursday's trading session at $0.4374, down 3.66%, on 108,438 volume with 86 trades. The average volume for the last 3 months is 272,256 and the stock's 52-week low/high is $0.30/$1.29.

chart

Bion Environmental Technologies, Inc. (BNET)

TopPennyStockMovers, StockGuru, Marketbeat, 4-Traders, Proactive Investors, SECFilings.com News, OTC Stock Review, and Wall Street Resources reported earlier on Bion Environmental Technologies, Inc. (BNET), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bion Environmental Technologies, Inc. is a developer of advanced livestock waste treatment and resource recovery technology. Its patented, next-generation technology provides verified comprehensive treatment of animal waste from large-scale livestock production facilities. Bion Environmental Technologies is headquartered in Crestone, Colorado. The Company’s administrative office is in Old Bethpage, New York. Bion lists on the OTC Markets Group’s OTCQB.

Bion’s technology platform is a modular system. It can be configured in an array of ways, depending on farm- and region-specific needs. This system creates new revenue sources and opportunities for the producer. The Company’s technology platform achieves substantial reductions in environmental impacts. This includes nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, and pathogens in the waste stream. This is while improving resource and operational efficiencies via the recovery of valuable byproducts.

Bion’s 2nd generation (2G) Comprehensive Environmental Management System removes up to 95 percent of the nutrients from the livestock waste effluent. It considerably decreases air emissions. This includes ammonia (as great as 90 percent or more), greenhouse gases, hydrogen sulfide, VOC’s, and others. The system extracts renewable energy from the waste stream in the form of cellulosic biomass.

The Company’s treatment solutions are a combination of biological, mechanical, as well as thermal processes. These are proven in commercial operations. They have been accepted by the EPA (Environmental Protection Agency), the USDA (United States Department of Agriculture), and other regulatory agencies.

Recently, Bion Environmental Technologies announced it filed an application under the Patent Cooperation Treaty (PCT) for international recognition of its process to produce a quick-release organic nitrogen fertilizer from livestock waste. The PCT application allows the Company to file patent applications and seek protection in most major market countries globally. The U.S. Patent and Trademark Office (USPTO) issued Patent No. 10,106,447 B2 on October 23, 2018, the first patent issued on Bion's third-generation technology.

Bion Environmental Technologies, Inc. (BNET), closed Thursday's trading session at $0.74, up 0.68%, on 7,270 volume with 6 trades. The average volume for the last 3 months is 6,321 and the stock's 52-week low/high is $0.42/$0.80.

chart

Empire Diversified Energy, Inc. (MPIR)

PennyStockHub, Equity Net, Otc Dynamics, Hot Penny Stocks, MarketWatch, Penny Stock Tweets, Dividend Investor, Biz Journals, OTC Markets, InvestorsHub, Morningstar, Investing, Stockhouse, Stockopedia, YCharts, and Investors Hangout reported beforehand on Empire Diversified Energy, Inc. (MPIR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Empire Diversified Energy, Inc.’s primary goal is to serve the challenges of the energy Industry with inventive solutions mainly related to the safe removal and disposal of Coal Combustion Residue (CCR), typically referred to as coal ash, from the nation’s utilities storage ponds. Fundamentally, the Company’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire specializes in Diversified Green Energy projects. It is a full-service business. OTCQB-listed, Empire Diversified Energy is based in Fort Lauderdale, Florida.

The Company is currently initiating coal-reduction strategies involving increased use of sustainable biomass. Furthermore, Empire’s longer-term plans will be to diversify into zero-emission fuel science and the broad use of economically-viable hydro-electric, solar, and wind technologies. Empire provides strategic consulting and unique environmental solutions to address industry issues including the CCR remediation and renewable energy alternatives. The Company has identified a niche market opportunity in the fly ash remediation sector.

Empire plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment, and biomass inventories. This is because it is working to implement a vertical integration strategy. It is now developing a hybrid alternative fuel pellet (HAFP). The intention of HAFP is to permit utilities and other enterprises that now burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s. Empire is also developing its own proprietary binding agent. This binding agent will allow HAFP’s to be used across a broader array of platforms.

This past November, Empire Diversified Energy announced that it received the first tranche of investment funds from a private equity group. The funds were used to pay off existing debt related to the Dickerson site in Cadiz, Ohio and to expand operations at the site. This funding retired the remaining debt on the site, which was acquired with the purchase of 100 percent of the membership rights of DTE Dickerson LLC. A Michigan LLC in April of 2017. This financing also provides much needed working capital to expand the reclamation project.

Empire Diversified Energy, Inc. (MPIR), closed Thursday's trading session at $0.60, even for the day, on 2,570 volume. The average volume for the last 3 months is 303 and the stock's 52-week low/high is $0.597/$2.70.

chart

KULR Technology Group, Inc. (KUTG)

Penny Stock Hub, Bull Market Board, Business Wire, Simply Wall St, Fairly Valued, Investors Hangout, Insights Success, MarketWatch, InvestorsHub, Stockhouse, Trading View, otc.watch, Stockaholics, Street Insider, and Market Screener reported previously on KULR Technology Group, Inc. (KUTG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

KULR Technology Group, Inc.’s mission is to use space technologies to make e-mobility cooler and safer. The Company’s focus is to make electronics ​cooler, lighter, and also safer with carbon fiber-based thermal management technology. The Company previously went by the name KT High-Tech Marketing, Inc. It changed its corporate name to KULR Technology Group, Inc. in August of last year. KULR Technology Group has its head office in California.

The Company states that its high-performance, passive thermal management technologies for electronics and energy storage applications have an inventive patented carbon fiber architecture that outperforms traditional solutions. KULR is progressing towards commercializing disruptive cooling solutions on a larger scale with a main emphasis on high value space, industrial, defense and electric vehicle markets. Its secondary goal is to commercialize within the consumer electronics, mobile and cloud computing markets.

KULR has an active developmental partnership with NASA (National Aeronautics and Space Administration). The Company also has an exclusive license with NREL, a national laboratory of the U.S. Department of Energy. Additionally, KULR has manufacturing scalability via international partnerships.

This past October, KULR Technology announced that NASA placed an initial order for the Internal Short Circuit (ISC) trigger battery cells that can replicate lithium-ion battery cell failures in battery pack designs. The ISC is licensed, manufactured and distributed by KULR under an exclusive agreement with the DOE’s National Renewable Energy Laboratory (NREL).

KULR fiber (as pure carbon) is perfectly heat efficient. It behaves like a flexible fabric. As a result, it can fit with just about any power or electronic configuration in extremely demanding spaces with minimal contact pressure. This can increase efficiency and safety for an array of thermal management and energy storage uses across an assortment of markets.

Recently, KULR Technology Group announced that the United States Patent and Trademark Office (USPTO) awarded the Company a patent on its Thermal Runaway Shield (TRS). This is a technology designed and successfully tested to lessen the fire, explosion and other risks associated with thermal runaway in lithium-ion battery packs.

Dr. Timothy Knowles, Co-Founder and Chief Technology Officer of KULR Technology Group, and first named inventor of the patent, said, “The awarding of this patent is a big leap forward in our ongoing work to research and develop products that make batteries safer. We believe that designers, engineers and customers in a variety of markets, both current and new, will benefit from our innovative technology.”

KULR Technology Group, Inc. (KUTG), closed Thursday's trading session at $2.50, even for the day, on 11,900 volume. The average volume for the last 3 months is 595 and the stock's 52-week low/high is $1.10/$5.00.

chart

AIT Therapeutics, Inc. (AITB)

NetworkNewsWire, Zacks, Trading View, Barchart, Stockhouse, Stockopedia, Investor Place, Insider Financial, Street Insider, last10k, Wallet Investor, GuruFocus, Wolfstreet, MarketWatch, Emerging Growth, Morningstar, Real Investment Advice, 4-Traders, and Tip Ranks reported previously on AIT Therapeutics, Inc. (AITB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AIT Therapeutics, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York. It focuses on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions. These include serious lung infections and pulmonary hypertension. AIT Therapeutics also has an office in Ness Ziona, Israel. The Company’s shares trade on the OTC Markets’ OTCQB and AIT has submitted an application to be up-listed on the NASDAQ stock exchange with potential approval and completion by the end of Q1 calendar 2019.

At present, AIT Therapeutics is applying its therapeutic expertise to treat lower respiratory tract infections not effectively addressed with current standards of care, and also pulmonary hypertension, in diverse settings. The Company is now advancing its pioneering NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections. This includes nontuberculous mycobacteria (NTM).

AIT’s propriety generator and delivery system generates NO from room air. This eliminates the requirement for costly and cumbersome cylinders. The Company’s system allows for numerous significant advantages over approved NO cylinder based systems now used in hospitals globally and may allow for use in the home setting.

NO is recognized as an important molecule involved in many physiological and pathological processes. NO is naturally produced by the body’s immune system to provide a first line of defense against invading pathogens. NO is a powerful molecule and has a short half-life of a few seconds in the blood. This enables it to be cleared fast from the body.

AIT Therapeutics has a commercial licensing agreement with Circassia Pharmaceuticals for AIT’s novel, cylinder free, ventilator compatible NO generator and phasic-flow delivery system (AirNOvent) in the U.S. and China for use in the hospital setting at NO concentrations <= 80 ppm. Circassia Pharmaceuticals is a respiratory-focused specialty pharmaceutical company.

This deal allows AIT Therapeutics to take advantage of Circassia’s expertise and footprint in specialty hospitals and the nitric oxide market in preparation for a potential U.S. launch in the first half of calendar 2020. AIT has already received $10.5 million in milestones from Circassia Pharmaceuticals and is entitled to $22.05 million of future milestone payments and meaningful royalties on gross profits.

AIT Therapeutics, Inc. (AITB), closed Thursday's trading session at $4.94, down 1.20%, on 9,653 volume with 9 trades. The average volume for the last 3 months is 5,786 and the stock's 52-week low/high is $2.05/$5.50.

chart

Two Rivers Water & Farming Company (TURV)

IRGnews Alert, 4-Traders, Marketwired, SmallCapVoice, Green Rush Review, Simply Wall St, TopPennyStockMovers, Insider Financial, Barchart, Stock News Now, Cannabis Financial Network News, Jet-Life Penny Stocks, and Stock Guru reported earlier on Two Rivers Water & Farming Company (TURV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the southwestern United States. The Company assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland through continually developing operations, which produce more revenues and better profit margins. Two Rivers Water & Farming has its headquarters in Denver, Colorado. GrowCo, Inc. is an indirect subsidiary of the Company (majority-owned subsidiary).

GrowCo was established in May of 2014 to build greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, via its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to build state-of-the-art greenhouse facilities for licensed marijuana growers. GrowCo concentrates on the construction of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

Two Rivers’ produce sells to national accounts by way of its wholly-owned subsidiary Dionisio Farms & Produce. Concerning Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, acquired in connection with its purchases of irrigated farmland.

Two Rivers Water & Farming has formed a separate company to focus on its existing and future investments in water. This new subsidiary is Water Redevelopment Company - a Delaware corporation. The Company’s first area of focus is in the Huerfano-Cucharas river basin in southeastern Colorado. Its present farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado.

Two Rivers provides greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Additionally, the Company develops Metropolitan Districts to serve underserved communities in rural areas in which Two Rivers' farmland and water rights are located.

Two Rivers Water & Farming Company earlier announced that it is making significant progress on its hemp crop share arrangement and water redevelopment project. The Company stated that land development sales are progressing ahead of plan. Two Rivers' hemp crop share arrangement is with a southern Colorado hemp grower. Two Rivers’ core focus is its water assets. Therefore, work continues toward the monetization of its water assets. 

Two Rivers Water & Farming Company (TURV), closed Thursday's trading session at $0.23, up 12.20%, on 384,542 volume with 70 trades. The average volume for the last 3 months is 325,800 and the stock's 52-week low/high is $0.079/$0.349.

chart

Escalon Medical Corp. (ESMC)

Stock Twits, Morningstar, OTCPicks, MarketWatch, Stockhouse, Wall Street Resources, FeedBlitz, and PennyToBuck reported earlier on Escalon Medical Corp. (ESMC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. It is working to grow its ophthalmic business through further developing and diversifying its product offering via internal development programs, strategic partnerships, and the acquisition of technology to best take advantage of its distribution capabilities.

Escalon Medical has research and development (R&D), manufacturing, and distribution operations in New Hyde Park, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. OTCQB-listed, the Company has its head office in Wayne, Pennsylvania.

Escalon Medical markets its products by way of independent sales representatives. The Company primarily markets to teaching institutions, hospitals, and eye surgery centers.

In 2000, Escalon Medical acquired Sonomed, Inc. Since then, via acquisition, product divestitures, partnerships, and product development, the Company has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

Escalon Medical’s products include an assortment of ophthalmic ultrasound, digital imaging and photography, and image management systems. In addition, its products include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments. All of its ophthalmic products are branded as Sonomed Escalon. Moreover, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices.

The Sonomed Escalon group is a leader in ophthalmic diagnostics imaging. Sonomed Escalon provides ultrasound, digital photography, and image management systems. Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products.

Sonomed Escalon offers its Vu Pad in regard to Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. It is configurable with B-scan, A-scan, UBM or any combination. Furthermore, surgical solutions offered include vitreoretinal gases and devices. The Company’s diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vision analysis; adaptive refractor; perimetry; digital imaging, and tonometry.

Escalon Medical Corp. (ESMC), closed Thursday's trading session at $0.11, up 4.27%, on 362 volume with 2 trades. The average volume for the last 3 months is 7,728 and the stock's 52-week low/high is $0.105/$0.36.

chart

MYM Nutraceuticals, Inc. (MYMMF)

Stockhouse, MarketWatch, OTC Markets, Barchart, Investing, InvestorsHub, and Market News Updates reported on MYM Nutraceuticals, Inc. (MYMMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MYM Nutraceuticals, Inc. focuses on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. The Company is looking to acquire complementary businesses and assets in the technology, nutraceuticals, and CBD sectors. MYM is the sole owner of CBD brands HempMed, Joshua Tree, and Dr. Furbaby. MYM Nutraceuticals is based in Vancouver, British Columbia.

Dr. Furbaby is the Company’s CBD line of products specifically for pets. HempMed is targeted at the dispensary market. Joshua Tree is targeted for the mainstream health market.

Currently, MYM Nutraceuticals is constructing three large-scale production facilities in Canada and Australia. These are the Northern Rivers Project; the Weedon Project; and the Laval Project. Upon completion, the total amount of greenhouse growing space will be more than 2.7 million square feet.

The Laval Project facility (Laval, Quebec) is 10,000 sq. ft. It will undergo expansion to 26,000 sq. ft. by 2019. The estimation is that the Laval Project will generate sales of $20 million by 2019.

The Northern Rivers Project (Casino, New South Wales, Australia) is a 1.2 million sq. ft. greenhouse project. The expectation is that the first crop will be planted in Q4 2018. The Northern Rivers Project facility is believed to be the Southern Hemisphere's largest purpose-built greenhouse, designed specifically to produce medical-grade cannabis.

The Weedon Project is in Weedon, Quebec. This Project will include a cannabis museum and a cannabis university for industry training. The Weedon Project has 1.5 million sq. ft. of greenhouse. MYM received approval and started Phase One construction of the Weedon production facility.

Additionality, the Company has its MJT Manufacturing Project (Toronto, Ontario). The 5,000 sq. ft. production facility is a GMP (Good Manufacturing Practice) certified, state-of-the-art extraction lab and production facility dedicated to industrial hemp processing (CBD). MYM Nutraceuticals has acquired an additional 18 percent of CannaCanada and the Weedon, Quebec project bringing its total ownership of the late stage ACMPR applicant, up to 93 percent.

Last week, MYM Nutraceuticals announced that it entered into a partnership with the University of Sherbrooke to study the medicinal and industrial uses of cannabis and hemp. Researchers at the University of Sherbrooke will work with an on-site coordinator to establish partnerships through targeting expertise in different faculties and training centers.

Mr. Rob Gietl, MYM Nutraceuticals’ Chief Executive Officer, said, "The signing of this partnership agreement with University of Sherbrooke furthers our goal to be at the forefront of cannabis plant research and development. Furthermore, I am delighted to see our company associated with a large Quebec university that has an outstanding reputation in research and innovation."

MYM Nutraceuticals, Inc. (MYMMF), closed Thursday's trading session at $0.4057, up 3.65%, on 88,498 volume with 71 trades. The average volume for the last 3 months is 151,670 and the stock's 52-week low/high is $0.3322/$2.0585.

chart

Inception Mining, Inc. (IMII)

Stock Commander, Streetwise Reports, PennyStocks24, Information Solutions Group, and Charms Investments reported previously on Inception Mining, Inc. (IMII), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Inception Mining, Inc. engages in the acquisition, exploration, and development of precious metal properties - principally gold-related. The Company’s chief target properties are those that have been the subject of historical exploration having substantial supporting data. Inception Mining is based in Murray, Utah.

In August 2014, Inception Mining announced that it entered into an Ore Processing Agreement with New Jersey Mill Joint Venture (NJ Mill), a floatation mill that can process 360 metric tonnes daily. The mill is in Kellogg, Idaho. NJ Mill will process Inception Mining's bulk samples.

Inception Mining holds interest in the U.P. and Burlington Gold Mine. This includes two Federal patented mining claims in the County of Lemhi, Northwest of Salmon, Idaho. The U.P. and Burlington Mine is within the Salmon National Forest. The mine is considered to be within the Eureka Mining District.

Clavo Rico Ltd. is the Company’s wholly-owned subsidiary. It assumed management control of Clavo Rico’s operation, the Cerros Del Sur operation in Honduras, Central America. Clavo Rico has primary operations in Honduras. Clavo Rico operates two subsidiaries and holds other mining concessions. Inception Mining’s main mine is positioned on the 200 hectare Clavo Rico Concession, in southern Honduras.

Inception Mining announced in October of 2017 the completion of the expansion project at its Clavo Rico Project. The processing capacity of excavation, hauling, and crushing facilities was increased to 500 -750 tpd. In addition, stacking capacity of the leach pad was increased from 400,000 tonnes to more than 750,000 tonnes.

Inception Mining also announced in October 2017 that it entered into a Joint Venture (JV) Agreement with Corpus Mining and Exploration Ltd., a company domiciled in the Turks and Caicos. The JV will result in the establishment of a new company, Corpus Gold LLC. With this JV Agreement, Inception Mining will direct and supervise all exploration, drilling, and evaluation initiatives on the Concession.

Pertaining to the above-mentioned Cerros del Sur operation, the Company continues to make improvements in operations and recovery, along with increasing its ore resources. Mine management has secured more mineable properties on its concession. A number of adjacent landowners have placed the surface rights of their lands under contract with the mine.

Inception Mining, Inc. (IMII), closed Thursday's trading session at $0.189, up 5.00%, on 5,008 volume with 2 trades. The average volume for the last 3 months is 2,780 and the stock's 52-week low/high is $0.0002/$0.30.

chart

Lion One Metals Limited (LOMLF)

TopStocks, Barchart, Stockhouse, Stock Twits, Investors Hub, OTC Markets, Junior Mining Network, MarketWatch, Morningstar, Nasdaq, Canadian Mining Report, ‎Investor Ideas, StreetWise Reports, TradingView, Mining Atlas, Mining, Stock World, and Investing reported on Lion One Metals Limited (LOMLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lion One Metals Limited focuses on advancing to production at its 100 percent owned and fully permitted high grade underground Tuvatu Gold Project. Tuvatu is situated on the island of Viti Levu in the Republic of Fiji. A mineral exploration and development company Lion One Metals is based in Vancouver, British Columbia. The Company lsists on the OTC Markets’ OTCQX. Lion One Metals also offices in Fremantle, Australia and in Waimalika, Nadi, Republic of Fiji.

Lion One Metals is focused on cost effective and environmentally responsible construction, development, and advancement of Tuvatu towards production. This is tied with exploration of its district-scale license areas covering the highly prospective and underexplored Navilawa volcano. The Company is advancing Tuvatu as a near-term production opportunity with exploration upside in the southwest Pacific Ring of Fire.

Lion One Metals has modeled Tuvatu for exploration after regional giants in the low sulphidation family of high grade epithermal gold deposits. This includes Porgera and Lihir in Papua New Guinea, and Vatukoula in Fiji, which boast production of greater than 35 million ounces of gold in similar alkaline volcanic settings.

The Company is centered on building production of 100,000 oz. per year over 10 years. Lion One Metals holds a 200 km² exploration license package encompassing the entire Navilawa volcano, with the Tuvatu mining lease at its center. Tuvatu is the largest undeveloped gold project in Fiji. Furthermore, it is one of the highest-grade gold projects anywhere in the world.

Lion One Metals announced in February 2018 that an expansive surface exploration program began at its high grade Tuvatu Gold Project. The 2018 surface program is being carried out within the permitted area of the Tuvatu Mining Lease (SML 62). It comprises Phase One, which includes excavator benching with detailed mapping and sampling, followed by a Phase Two drilling program.

Recently, Lion One Metals announced that it entered into an indicative term sheet with Sinosteel Equipment & Engineering Co., Ltd. of China and Baiyin International Investment Ltd. This term sheet incorporates an EPC and gold doré off-take financing facility totaling US$40 million for mine development and construction of the processing plant for Lion One Metals’ Tuvatu Gold Project.

Following the discovery of a new mineralized lode from benching, which returned a (non-representative) select sample of 502 g/t gold over 0.70 m, Lion One's Fiji exploration team has mapped over 20 previously undefined mineralized structures at the Jomaki-Ura Creek prospect areas. The team has also identified potential geological extensions on the main mineralized zones inside the Tuvatu Mining Lease (SML 62).

Lion One Metals Limited (LOMLF), closed Thursday's trading session at $0.3971, down 0.23%, on 16,900 volume with 10 trades. The average volume for the last 3 months is 10,423 and the stock's 52-week low/high is $0.244/$0.615.

chart

Almost Never Films, Inc. (HLWD)

The Street, YCharts, Simply Wall St, Dividend Investor, Street Insider, Market Exclusive, MarketWatch, and Marketbeat reported on Almost Never Films, Inc. (HLWD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Almost Never Films, Inc. is an independent film company based in Los Angeles, California. Its focus is on film production, finance and production related services for movies under budgets of $35 million. Its business is to enable relationships between creative talent and companies who produce, finance and distribute motion pictures. Almost Never Films lists on the OTC Markets Group’s OTCQB.

The Company’s goal is to create, acquire, or license rights to materials upon which it believes motion pictures can be based. Mr. Danny Chan is the Chief Executive Officer (CEO) of Almost Never Films. He is also a Managing Director of Iconic Private Equity Partners, headquartered in Hong Kong.

In November 2017, Almost Never Films announced that it entered into a strategic partnership with Pure Flix Entertainment. The new partnership is a multi-film financing agreement to produce six faith-based original motion pictures. Pure Flix Entertainment is a U.S. independent Christian film and television studio, based in Scottsdale, Arizona. Pure Flix Entertainment will distribute the films internationally in new media format. Almost Never Films will contribute its financial, development, and production services.

Almost Never Films announced in December 2017 its teaming with Howard and Karen Baldwin of Kemb Productions, Stuart Benjamin Productions, and Nick Cassavetes to develop a scripted television series. Nick Cassavetes will write the pilot, which follows the rise and fall of Bruce McNall, a self-made tycoon who owned the Los Angeles Kings of the National Hockey League (NHL), and who was also deeply involved in the high profile worlds of antiquities, coins, race horses, film and sports.

Almost Never Films announced this past February that it completed principle photography of the faith-based film "Bethlehem Ranch". The cast of the feature film includes Tara Reid. Almost Never Films and Big Film Factory, LLC are producing this film. Pure Flix Entertainment will be distributing "Bethlehem Ranch" around the world in new media format.

This past June, Almost Never Films announced that it will finance and produce the second season of "The Chair". This is a reality series that follows two up-and-coming directors through the process of making their first film based on the same source material. Academy Award nominated producer Chris Moore created the reality series. Mr. Moore will serve as executive producer of season two along with Josh Shader and Tony Sacco from season one.

Almost Never Films, Inc. (HLWD), closed Thursday's trading session at $1.20, up 26.32%, on 3,587 volume with 3 trades. The average volume for the last 3 months is 12,593 and the stock's 52-week low/high is $0.30/$2.51.

chart

Abattis Bioceuticals Corp. (ATTBF)

Greenbackers, Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, Stockgoodies, Cannabis Financial Network News, PennyStocks24, and Information Solutions Group reported previously on Abattis Bioceuticals Corp. (ATTBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a life sciences and biotechnology company based in Vancouver, British Columbia (BC). The Company has an operations office in Langley, BC. Abattis aggregates, integrates and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. OTCQB-listed, Abattis Bioceuticals has positioned itself to be a leading service provider in the cannabis industry.

The Company’s brands include Northern Vine Labs™ and Vergence Naturals™. Abattis is also working to acquire exclusive intellectual property (IP) rights to agricultural technologies to be used in the extraction and processing of botanical ingredients and compounds.

Abattis has, through its operations and wholly-owned subsidiaries, a broad array of capabilities. These include cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

The Company has a Federally Licensed Testing Lab. Its Northern Vine Labs holds a controlled substance dealers license from Health Canada. Northern Vine Labs' product formulation specialists can create and consult on custom developed products. Abattis Bioceuticals also has exclusive distribution rights to sell and service an industrial scale and cost-effective extraction technology.

Abattis Bioceuticals announced this past March that it completed its acquisition of a 90 percent ownership interest in Gabriola Green Farms, Inc. Gabriola is a BC company. Gabriola has applied for a license to produce (LP) under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of BC. Gabriola currently has plans for an approximately 26,000 square-foot production facility to produce medical-grade marijuana located on 18 acres in the agricultural land reserve on Gabriola Island, BC.

In July, Abattis Bioceuticals announced that it entered into a definitive agreement with Emerald Health Therapeutics, Inc. to dispose of its 35 percent interest in Northern Vine Canada, Inc. in exchange for $2 million in cash and $4 million in freely tradeable common shares of Emerald Health Therapeutics.

In connection with this Agreement, Abattis Bioceuticals entered into a Master Services Agreement with Northern Vine to provide for Abattis’s continued use of Northern Vine’s laboratory as a “preferred customer”. This includes Abattis’s development work on a hemp-infused cannabinoid-rich, THC-free craft beer with Faculty Brewing Co. and also on nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil with the University of British Columbia.

Additionally, in July, Abattis Bioceuticals announced that it closed its investment in XLABS Therapeutics (ONT), Inc. Abattis and XLABS will be launching a new cannabis laboratory in Belleville, Ontario, to serve Ontario’s rising cannabis sector. The Laboratory (the Belleville Facility) will be housed in a 320,000 square foot building. Plans are for an initial build-out of 10,000 square feet and future expansion into the remaining 310,000 square feet via organic growth and more joint ventures (JVs).

This month it was reported that Emerald Health Therapeutics completed the purchase of the remaining shares of Northern Vine Canada, Inc. from Abattis Bioceuticals. The transaction increases Emerald’s ownership of Northern Vine from 65 percent to 100 percent.

Abattis Bioceuticals Corp. (ATTBF), closed Thursday's trading session at $0.045, up 0.33%, on 458,234 volume with 55 trades. The average volume for the last 3 months is 738,783 and the stock's 52-week low/high is $0.029/$0.30.

chart

The QualityStocks Company Corner

City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

On March 5, 2019, the company formally known as Icon Exploration Inc. (TSX.V: IEX.H) opened on the Canadian Securities Exchange under new corporate name City View Green Holdings Inc. (CSE: CVGR). The company’s focus continues to be on assessing and potentially acquiring targets in the cannabis industry through diversification. The full announcement and explanation of consolidation for registered shareholders can be found at http://nnw.fm/li9YA.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $0.17, off by 19.05%, on 3,143,147 volume with 373 trades. The stock's 52-week low/high is $0.145/$0.465.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. A committee of the Idaho State Assembly has approved funding so that the state police can buy the equipment needed to test whether a given plant is industrial hemp or marijuana. This plan comes after the police seized a semitrailer carrying what the arresting officer thought was marijuana while the driver and his employer insisted that the consignment contained hemp.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.6008, up 2.19%, on 29,061 volume with 113 trades. The average volume for the last 3 months is 89,883 and the stock's 52-week low/high is $2.8099/$6.008.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Canadian Licensed Producer of premium cannabis products the Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) announced that it has promoted Jason Broome from SVP of operations to the role of chief research and innovation officer (“CRIO”). To view the full press release, visit: http://nnw.fm/5qzLO.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $6.00, up 9.29%, on 330,267 volume with 824 trades. The average volume for the last 3 months is 128,701 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

The volume of contracts – $5.8 million – won by Spectrum Global Solutions Inc. (OTCQB: SGSI) over the past 12 months shows that the engineering company is already benefiting as telecommunications carriers and large corporate enterprises upgrade their systems (http://nnw.fm/TzmC9). Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.2699, up 107.62%, on 1,550,405 volume with 547 trades. The average volume for the last 3 months is 52,785 and the stock's 52-week low/high is $0.071/$2.59.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), today announced the strengthening of its board of directors (the "Board") with the appointment of a new independent director, Kenneth R. McKinnon, Q.C. As an experienced corporate executive and director, Mr. McKinnon brings substantial financial oversight and business advisory experience to the Company's Board. Also today, the company was highlighted in an article examining how the marijuana stock market has come a long way in the last few years, largely in part to a recent push for legislation in support of legalization.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.57, up 6.80%, on 3,680,801 volume with 3,840 trades. The average volume for the last 3 months is 453,206 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced that it has engaged Derek Lindsay as a consultant to assist ETST with potential dual listing of the company’s common shares on the Canadian Securities Exchange (“CSE”), as well as implement an investor relations program and other items. To view the full press release, visit: http://nnw.fm/Wi9Py.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7125, up 6.03%, on 57,061 volume with 53 trades. The average volume for the last 3 months is 33,533 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to provide an update on its retail development strategy as an emerging consumer cannabis company that has secured one of the largest retail networks in Canada. Also today, the company was highlighted in an article looking at how The Brightfield Group has gotten quite a lot of ink lately… for their projections that the hemp derived CBD market will outpace the “Rest of the cannabis market COMBINED.” 

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.3905, up 3.72%, on 1,387,000 volume with 632 trades. The average volume for the last 3 months is 341,415 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) shares a video interview between Direct Solar founder and Wil Ralston, President of SinglePoint. Direct Solar is SinglePoint most recent deal and upon completion of audit the transaction will be formally completed. Direct Solar has the opportunity to double SinglePoint revenue and expand nationwide increasing sales and profits for the company immensely. Video Interview - https://youtu.be/jl0u8eZpUrI.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01885, off by 0.79%, on 1,986,088 volume with 134 trades. The average volume for the last 3 months is 6,178,789 and the stock's 52-week low/high is $0.0106/$0.0698.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

NetworkWire - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a client of NNW and immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer. The interview can be heard at http://nnw.fm/xCvB7.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0849, off by 2.08%, on 19,500 volume with 3 trades. The average volume for the last 3 months is 19,621 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how the stated total of all concentrate revenue in California for that same period was $140.9 million… Based on those figures, it’s clear that vape cartridges dominate sales. But why? The simple answer: user convenience.” 

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.1755, off by 4.06%, on 1,442,250 volume with 1,960 trades. The average volume for the last 3 months is 1,137,293 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSXV: RIV) congratulates its portfolio company Headset, Inc. (“Headset”) on the formation of its landmark strategic alliance with Nielsen Holdings plc (“Nielsen”) (NYSE: NLSN). Yesterday, Nielsen and Headset together announced an alliance that will provide U.S. cannabis market data and analytics to consumer packaged goods (CPG) companies monitoring the cannabis space.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.38, off by 4.16%, on 616,496 volume with 1,270 trades. The average volume for the last 3 months is 590,256 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Pacific Rim Cobalt Corp. (OTCQB: PCRCF) (CSE: BOLT), a client of NNW focused on the development of nickel and cobalt projects within Indonesia. To view the full publication, titled “Growing Demand for Nickel for Batteries Drives Increased Investments in Indonesian Nickel Sector,” visit: http://nnw.fm/W474y.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.1725, up 10.44%, on 48,330 volume with 18 trades. The average volume for the last 3 months is 24,863 and the stock's 52-week low/high is $0.0701/$0.568.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) was featured today in the 420 with CNW by CannabisNewsWire. A committee of the Idaho State Assembly has approved funding so that the state police can buy the equipment needed to test whether a given plant is industrial hemp or marijuana. This plan comes after the police seized a semitrailer carrying what the arresting officer thought was marijuana while the driver and his employer insisted that the consignment contained hemp.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.1706, off by 0.29%, on 549 volume with 2 trades. The average volume for the last 3 months is 275 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis industry incubator Cannabis Strategic Ventures (OTC: NUGS) recently strengthened its portfolio with the addition of the six-acre Northern California NUGS Farm. To view the full article, visit: http://nnw.fm/sZ5f8.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.21, up 0.21%, on 85,408 volume with 89 trades. The average volume for the last 3 months is 124,181 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.